High dose rate brachytherapy (HDR-BT) in locally advanced oesophageal cancer. Clinic response and survival related to biological equivalent dose (BED)

Clinical and Translational Oncology

Volumn 9, Issue 6, 2007, Pages 385-391

  López Carrizosa, Ma Concha ^a   Samper Ots, P M ^a   Rodriguez Perez A ^a   Sotoca, A ^a   Saez Garrido J ^a   Miguel, M M ^a  

^a HOSPITAL CENTRAL DE LA DEFENSA GÓMEZ ULLA   (Spain)

Author keywords

HDR brachytherapy; Oesophageal cancer; Radio chemotherapy

Indexed keywords

CISPLATIN; FLUOROURACIL; IRIDIUM 192;

ACUTE TOXICITY; ADULT; ADVANCED CANCER; AGED; ARTICLE; BIOLOGICAL EQUIVALENT DOSE; BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONFORMAL THREE DIMENSIONAL RADIOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOSIMETRY; DRUG MEGADOSE; ESOPHAGUS CANCER; FEMALE; HIGH DOSE RATE BRACHYTHERAPY; HUMAN; MALE; MULTIPLE CYCLE TREATMENT; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIOLOGICAL PARAMETERS; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; SURVIVAL TIME; TREATMENT DURATION; TREATMENT RESPONSE; TUMOR LOCALIZATION; COMPARATIVE STUDY; ESOPHAGUS TUMOR; METHODOLOGY; MIDDLE AGED; MORTALITY;

ADULT; AGED; AGED, 80 AND OVER; BRACHYTHERAPY; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; RADIOTHERAPY DOSAGE; SURVIVAL RATE;

EID: 34848922743     PISSN: 1699048X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12094-007-0071-y     Document Type: Article

References (36)

1. Jemal A, Thomas A, Murray T et al (2002) Cancer statistics 2002. CA Cancer J Clin 52:23-47
2. Daly JM, Karnell LH, Menck HR (1996) National cancer data base report on esophageal carcinoma. Cancer 78:1820-1828
3. Lagergren J, Bergstrom R, Lindgren A et al (1999) Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 340:825-831
4. Koop H (2002) Gastroesophageal reflux disease and Barrett's esophagus. Endoscopy 34:97-103
5. Earlam R, Cunha-Melo JR (1980) Oesophageal squamous cell carcinoma: II. A critical view of radiotherapy. Br J Surg 67:457-461
6. Muller JM, Erasmo H, Stelzner M et al (1990) Surgical therapy of oesophageal carcinoma. Br J Surg 77:845-857
7. Roth JA, Putnam JB Jr (1994) Surgery for cancer of the esophagus. Semin Oncol 21:453-461
8. Wobst A, Audisio RA, Colleoni M et al (1998) Oesophageal cancer treatment: Studies, strategies, facts. Ann Oncol 9:931-942
9. Herskovic A, Marz K, Al-Sarraf M et al (1992) Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 326:1593-1598
10. Kelsen DP, Ginsberg R, Pajak TF et al (1998) Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med 339:1979-1984
11. Clark P (2001) Surgical resection with or without pro-operative chemotherapy in oesophageal cancer: An updated analysis of a randomized controlled trial conducted by the UK Medical Research Council Upper GI Tract Cancer Group. Proc Am Soc Clin Oncol 20:126 a (abstract 502)
12. Urba SG, Orringer MB, Turrisi A et al (2001) Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol 19:305-313
13. Heath EI, Burtness BA, Heitmiller R et al (2000) Phase II evaluation of preoperative chemoradiation and postoperative adjuvant chemotherapy for squamous cell and adenocarcinoma of the esophagus. J Clin Oncol 18:868-876
14. Cooper JS, Guo MD, Herskovic A et al (1999) Chemoradiotherapy of locally advanced esophageal cancer: Long-term follow-up of a prospective randomized trial (RTOG 85-01). JAMA 281:1623-1627
15. De-Ren S (1989) Ten years follow-up of esophageal cancer treated by radical radiation therapy: Analysis of 869 patients. Int J Radiat Oncol Biol Phys 16:329-334
16. Maingon P, d'Hombres A, Truc G et al (2000) High dose rate brachytherapy for superficial cancer of the esophagus. Int J Radiat Oncol Biol Phys 46:71-76
17. Delcambre C, Jacob JH, Portier D et al (2001) Localized squamous-cell cancer of the esophagus: Retrospective analysis of three treatment schedules. Radiother Oncol 59:195-201
18. Tai P, VanDyk J, Yu E et al (1998) Variability of target volume delineation in cervical esophageal cancer. Int J Radiat Oncol Biol Phys 42:277-288
19. Yu E, Dar R, Rodrigues GB et al (2004) Is extended volume external beam radiation therapy covering the anastomotic site beneficial in post-esophagectomy high risk patients? Radiother Oncol 73:141-148
20. Kato H, Tachimori Y, Watanabe H et al (1998) Anastomotic recurrence of esophageal squamous cell carcinoma alter trasnthoracic oesophagectomy. Eur J Cancer 164:759-764
21. Kyriazanos ID, Tachibana M, Shibakita M et al (2003) Pattern of recurrence after extended esophagectomy for squamous cell carcinoma of the esophagus. Hepatogastroenterology 50:115-120
22. Minsky BD, Pajak TF, Ginsberg RJ et al (2002) INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: High-dose versus standard-dose radiation therapy. J Clin Oncol 20:1167-1174
23. Okawa T, Dokiya T, Nishio M et al (1999) Multi-institutional randomized trial of external radiotherapy with and without intraluminal brachytherapy for esophageal cancer in Japan. Int J Radiat Oncol Biol Phys 45:623-628
24. Yorozu A, Dokiya T, Oki Y (1999) High-dose-rate brachytherapy boost following concurrent chemoradiotherapy for esophageal carcinoma. Int J Radiat Oncol Biol Phys 45:271-275
25. Okawa T (1999) Clinical optimization study of radiotherapy for esophageal cancer. J Jpn Soc Ther Radiol Oncol 11:53-58
26. Akagi Y, Hirokawa Y, Kagemoto M et al (1999) Optimum fractionation for high-dose-rate endoesophageal brachytherapy following external irradiation for early stage esophageal cancer. Int J Radiat Oncol Biol Phys 43:525-530
27. Calais G, Dorsal E, Louisot P et al (1997) Radiotherapy with high dose rate brachytherapy boost and concomitant chemotherapy for stages IIB and III esophageal carcinoma: Results of a pilot study. Int J Radiat Oncol Biol Phys 38:769-775
28. Hujala K, Sipilä J, Minn H et al (2002) Combined external and intraluminal radiotherapy in the treatment of advanced oesophageal cancer. Radiother Oncol 64:41-45
29. Sur RK, Levin CV, Donde B et al (2002) Prospective randomized trial of HDR brachytherapy as a sole modality in palliation of advanced esophageal carcinoma - an International Atomic Energy Agency study. Int J Radiat Oncol Biol Phys 53:127-133
30. Hishikawa Y, Kurisu K, Taniguchi M et al (1991) High-dose-rate intraluminal brachytherapy (HDRIBT) for esophageal cancer. Int J Radiat Oncol Biol Phys 21:1133-1135
31. Datta NR, Kumar S, Nangia S et al (1998) A non-randomized comparison of two radiotherapy protocols in inoperable squamous cell carcinoma of the oesophagus. Clin Oncol 10:306-312
32. Gaspar LE, Nag S, Herskovic A et al (1997) American Brachytherapy Society (ABS) consensus guidelines for brachytherapy of esophageal cancer. Clinical Research Committee, American Brachytherapy Society, Philadelphia, PA. Int J Radiat Oncol Biol Phys 38:127-132
33. Chirat E (2003) La curiethérapie endo-oesophagienne. Cancer Radiother 7:132-135
34. Marinello G, Pierquin B, Grimard L et al (1992) Dosimetry of intraluminal brachytherapy. Radiother Oncol 23:213-216
35. Geh JI, Bond SJ, Bentzen SM et al (2006) Systematic overview of preoperative (neoadjuvant) chemoradiotherapy trials in oesophageal cancer: Evidence of a radiation and chemotherapy dose response. Radiother Oncol 78:236-244
36. Suntharalingam M (2006) Definitive chemoradiation in the management of locally advanced esophageal cancer. Semin Radiat Oncol 17:22-28